Large-scale nucleotide optimization of simian immunodeficiency virus reduces its capacity to stimulate type I interferon in vitro

Journal of Virology

Volumn 88, Issue 8, 2014, Pages 4161-4172

  Vabret, Nicolas ^a,b   Bailly Bechet, Marc ^b   Lepelley, Alice ^a   Najburg, Valérie ^a   Schwartz, Olivier ^a   Verrier, Bernard ^b   Tangy, Frédéric ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; INTERFERON; POL PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CODON; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DNA MODIFICATION; GENE MUTATION; GENE REPLICATION; GENE SEQUENCE; GENETIC STABILITY; GROUP SPECIFIC ANTIGEN GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; NORMAL HUMAN; NUCLEIC ACID ANALYSIS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; STRUCTURAL GENE; VIRUS GENE;

ANIMALS; BASE SEQUENCE; HIV INFECTIONS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; INTERFERON TYPE I; MACACA MULATTA; MOLECULAR SEQUENCE DATA; MUTATION; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84896998604     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03223-13     Document Type: Article

References (73)

1. Holmes EC. 2011. What does virus evolution tell us about virus origins? J. Virol. 85:5247-5251. http://dx.doi.org/10.1128/JVI.02203-10.
2. Nurmemmedov E, Castelnovo M, Catalano CE, Evilevitch A. 2007. Biophysics of viral infectivity: matching genome length with capsid size. Q. Rev. Biophys. 40:327-356. http://dx.doi.org/10.1017/S0033583508004666.
3. Liu Y, Wimmer E, Paul AV. 2009. Cis-acting RNA elements in human and animal plus-strand RNA viruses. Biochim. Biophys. Acta 1789:495-517. http://dx.doi.org/10.1016/j.bbagrm.2009.09.007.
4. Baum A, Garcia-Sastre A. 2011. Differential recognition of viral RNA by RIG-I. Virulence 2:166-169. http://dx.doi.org/10.4161/viru.2.2.15481.
5. Gale M, Jr, Katze MG. 1998. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferoninduced protein kinase. Pharmacol. Ther. 78:29-46. http://dx.doi.org/10.1016/S0163-7258(97)00165-4.
6. Hu C, Saenz DT, Fadel HJ, Walker W, Peretz M, Poeschla EM. 2010. The HIV-1 central polypurine tract functions as a second line of defense against APOBEC3G/F. J. Virol. 84:11981-11993. http://dx.doi.org/10.1128/JVI.00723-10.
7. Mueller S, Coleman JR, Papamichail D, Ward CB, Nimnual A, Futcher B, Skiena S, Wimmer E. 2010. Live attenuated influenza virus vaccines by computer-aided rational design. Nat. Biotechnol. 28:723-726. http://dx.doi.org/10.1038/nbt.1636.
8. Mueller S, Papamichail D, Coleman JR, Skiena S, Wimmer E. 2006. Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity. J. Virol. 80:9687-9696. http://dx.doi.org/10.1128/JVI.00738-06.
9. Grantham R, Gautier C, Gouy M, Mercier R, Pave A. 1980. Codon catalog usage and the genome hypothesis. Nucleic Acids Res. 8:r49-r62.
10. Auewarakul P. 2005. Composition bias and genome polarity of RNA viruses. Virus Res. 109:33-37. http://dx.doi.org/10.1016/j.virusres.2004.10.004.
11. van der Kuyl AC, Berkhout B. 2012. The biased nucleotide composition of the HIV genome: a constant factor in a highly variable virus. Retrovirology 9:92. http://dx.doi.org/10.1186/1742-4690-9-92.
12. van Hemert FJ, van der Kuyl AC, Berkhout B. 2013. The A-nucleotide preference of HIV-1 in the context of its structured RNA genome. RNA Biol. 10:211-215. http://dx.doi.org/10.4161/rna.22896.
13. Berkhout B, Grigoriev A, Bakker M, Lukashov VV. 2002. Codon and amino acid usage in retroviral genomes is consistent with virus-specific nucleotide pressure. AIDS Res. Hum. Retroviruses 18:133-141. http://dx.doi.org/10.1089/08892220252779674.
14. Berkhout B, van Hemert FJ. 1994. The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins. Nucleic Acids Res. 22:1705-1711. http://dx.doi.org/10.1093/nar/22.9.1705.
15. Deforche K, Camacho R, Laethem KV, Shapiro B, Moreau Y, Rambaut A, Vandamme AM, Lemey P. 2007. Estimating the relative contribution of dNTP pool imbalance and APOBEC3G/3F editing to HIV evolution in vivo. J. Comput. Biol. 14:1105-1114. http://dx.doi.org/10.1089/cmb.2007.0073.
16. Bishop KN, Holmes RK, Sheehy AM, Malim MH. 2004. APOBECmediated editing of viral RNA. Science 305:645. http://dx.doi.org/10.1126/science.1100658.
17. Sheehy AM, Gaddis NC, Choi JD, Malim MH. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650. http://dx.doi.org/10.1038/nature00939.
18. Lesnik EA, Freier SM. 1995. Relative thermodynamic stability of DNA, RNA, and DNA:RNA hybrid duplexes: relationship with base composition and structure. Biochemistry 34:10807-10815. http://dx.doi.org/10.1021/bi00034a013.
19. Watts JM, Dang KK, Gorelick RJ, Leonard CW, Bess JW, Jr, Swanstrom R, Burch CL, Weeks KM. 2009. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 460:711-716. http://dx.doi.org/10.1038/nature08237.
20. Malathi K, Dong B, Gale M, Jr, Silverman RH. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: 816-819. http://dx.doi.org/10.1038/nature06042.
21. Li M, Kao E, Gao X, Sandig H, Limmer K, Pavon-Eternod M, Jones TE, Landry S, Pan T, Weitzman MD, David M. 2012. Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11. Nature 491: 125-128. http://dx.doi.org/10.1038/nature11433.
22. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M, Jr. 2008. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454:523-527. http://dx.doi.org/10.1038/nature07106.
23. Burns CC, Shaw J, Campagnoli R, Jorba J, Vincent A, Quay J, Kew O. 2006. Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region. J. Virol. 80: 3259-3272. http://dx.doi.org/10.1128/JVI.80.7.3259-3272.2006.
24. Coleman JR, Papamichail D, Skiena S, Futcher B, Wimmer E, Mueller S. 2008. Virus attenuation by genome-scale changes in codon pair bias. Science 320:1784-1787. http://dx.doi.org/10.1126/science.1155761.
25. Gutman GA, Hatfield GW. 1989. Nonrandom utilization of codon pairs in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 86:3699-3703. http://dx.doi.org/10.1073/pnas.86.10.3699.
26. Keating CP, Hill MK, Hawkes DJ, Smyth RP, Isel C, Le SY, Palmenberg AC, Marshall JA, Marquet R, Nabel GJ, Mak J. 2009. The A-rich RNA sequences of HIV-1 pol are important for the synthesis of viral cDNA. Nucleic Acids Res. 37:945-956. http://dx.doi.org/10.1093/nar/gkn1015.
27. Vabret N, Bailly-Bechet M, Najburg V, Muller-Trutwin M, Verrier B, Tangy F. 2012. The biased nucleotide composition of HIV-1 triggers type I interferon response and correlates with subtypeDincreased pathogenicity. PLoS One 7:e33502. http://dx.doi.org/10.1371/journal.pone.0033502.
28. Harris LD, Tabb B, Sodora DL, Paiardini M, Klatt NR, Douek DC, Silvestri G, Muller-Trutwin M, Vasile-Pandrea I, Apetrei C, Hirsch V, Lifson J, Brenchley JM, Estes JD. 2010. Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques. J. Virol. 84:7886-7891. http://dx.doi.org/10.1128/JVI.02612-09.
29. Jacquelin B, Mayau V, Targat B, Liovat AS, Kunkel D, Petitjean G, Dillies MA, Roques P, Butor C, Silvestri G, Giavedoni LD, Lebon P, Barre-Sinoussi F, Benecke A, Muller-Trutwin MC. 2009. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J. Clin. Invest. 119:3544-3555. http://dx.doi.org/10.1172/JCI40093.
30. Abdulhaqq SA, Weiner DB. 2008. DNA vaccines: developing new strategies to enhance immune responses. Immunol. Res. 42:219-232. http://dx.doi.org/10.1007/s12026-008-8076-3.
31. Barouch DH. 2006. Rational design of gene-based vaccines. J. Pathol. 208:283-289. http://dx.doi.org/10.1002/path.1874.
32. Li S, Locke E, Bruder J, Clarke D, Doolan DL, Havenga MJ, Hill AV, Liljestrom P, Monath TP, Naim HY, Ockenhouse C, Tang DC, Van Kampen KR, Viret JF, Zavala F, Dubovsky F. 2007. Viral vectors for malaria vaccine development. Vaccine 25:2567-2574. http://dx.doi.org/10.1016/j.vaccine.2006.07.035.
33. Marcheschi RJ, Staple DW, Butcher SE. 2007. Programmed ribosomal frameshifting in SIV is induced by a highly structured RNA stem-loop. J. Mol. Biol. 373:652-663. http://dx.doi.org/10.1016/j.jmb.2007.08.033.
34. Regier DA, Desrosiers RC. 1990. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 6:1221-1231.
35. Uze G, Di Marco S, Mouchel-Vielh E, Monneron D, Bandu MT, Horisberger MA, Dorques A, Lutfalla G, Mogensen KE. 1994. Domains of interaction between alpha interferon and its receptor components. J. Mol. Biol. 243:245-257. http://dx.doi.org/10.1006/jmbi.1994.1651.
36. Hilton L, Moganeradj K, Zhang G, Chen YH, Randall RE, McCauley JW, Goodbourn S. 2006. The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation. J. Virol. 80:11723-11732. http://dx.doi.org/10.1128/JVI.01145-06.
37. Gustafsson C, Govindarajan S, Minshull J. 2004. Codon bias and heterologous protein expression. Trends Biotechnol. 22:346-353. http://dx.doi.org/10.1016/j.tibtech.2004.04.006.
38. Akashi H, Eyre-Walker A. 1998. Translational selection and molecular evolution. Curr. Opin. Genet. Dev. 8:688-693. http://dx.doi.org/10.1016/S0959-437X(98)80038-5.
39. Ikemura T. 1985. Codon usage and tRNA content in unicellular and multicellular organisms. Mol. Biol. Evol. 2:13-34.
40. Comeron JM. 2004. Selective and mutational patterns associated with gene expression in humans: influences on synonymous composition and intron presence. Genetics 167:1293-1304. http://dx.doi.org/10.1534/genetics.104.026351.
41. Plotkin JB, Kudla G. 2011. Synonymous but not the same: the causes and consequences of codon bias. Nat. Rev. Genet. 12:32-42. http://dx.doi.org/10.1038/nrg2899.
42. Plotkin JB, Robins H, Levine AJ. 2004. Tissue-specific codon usage and the expression of human genes. Proc. Natl. Acad. Sci. U. S. A. 101:12588-12591. http://dx.doi.org/10.1073/pnas.0404957101.
43. Urrutia AO, Hurst LD. 2003. The signature of selection mediated by expression on human genes. Genome Res. 13:2260-2264. http://dx.doi.org/10.1101/gr.641103.
44. Caignard G, Komarova AV, Bourai M, Mourez T, Jacob Y, Jones LM, Rozenberg F, Vabret A, Freymuth F, Tangy F, Vidalain PO. 2009. Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor. PLoS Pathog. 5:e1000587. http://dx.doi.org/10.1371/journal.ppat.1000587.
45. Silvestri G. 2008. AIDS pathogenesis: a tale of two monkeys. J. Med. Primatol. 37(Suppl 2):6-12. http://dx.doi.org/10.1111/j.1600-0684.2008.00328.x.
46. Haller O, Stertz S, Kochs G. 2007. The Mx GTPase family of interferoninduced antiviral proteins. Microbes Infect. 9:1636-1643. http://dx.doi.org/10.1016/j.micinf.2007.09.010.
47. Amara A, Gall SL, Schwartz O, Salamero J, Montes M, Loetscher P, Baggiolini M, Virelizier JL, Arenzana-Seisdedos F. 1997. HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186:139-146. http://dx.doi.org/10.1084/jem.186.1.139.
48. Sattentau Q. 2008. Avoiding the void: cell-to-cell spread of human viruses. Nat. Rev. Microbiol. 6:815-826. http://dx.doi.org/10.1038/nrmicro1972.
49. Brennan K, Bowie AG. 2010. Activation of host pattern recognition receptors by viruses. Curr. Opin. Microbiol. 13:503-507. http://dx.doi.org/10.1016/j.mib.2010.05.007.
50. Lepelley A, Louis S, Sourisseau M, Law HK, Pothlichet J, Schilte C, Chaperot L, Plumas J, Randall RE, Si-Tahar M, Mammano F, Albert ML, Schwartz O. 2011. Innate sensing of HIV-infected cells. PLoS Pathog. 7:e1001284. http://dx.doi.org/10.1371/journal.ppat.1001284.
51. Jiang F, Ramanathan A, Miller MT, Tang GQ, Gale M, Jr, Patel SS, Marcotrigiano J. 2011. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 479:423-427. http://dx.doi.org/10.1038/nature10537.
52. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. 2005. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988. http://dx.doi.org/10.1038/ni1243.
53. Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, Grigorov B, Gerlier D, Cusack S. 2011. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147:423-435. http://dx.doi.org/10.1016/j.cell.2011.09.039.
54. Luo D, Ding SC, Vela A, Kohlway A, Lindenbach BD, Pyle AM. 2011. Structural insights into RNA recognition by RIG-I. Cell 147:409-422. http://dx.doi.org/10.1016/j.cell.2011.09.023.
55. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172. http://dx.doi.org/10.1038/nature04193.
56. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682. http://dx.doi.org/10.1016/j.cell.2005.08.012.
57. Wu B, Peisley A, Richards C, Yao H, Zeng X, Lin C, Chu F, Walz T, Hur S. 2013. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 152:276-289. http://dx.doi.org/10.1016/j.cell.2012.11.048.
58. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19:727-740. http://dx.doi.org/10.1016/j.molcel.2005.08.014.
59. Iwasaki A. 2012. A virological view of innate immune recognition. Annu. Rev. Microbiol. 66:177-196. http://dx.doi.org/10.1146/annurev-micro-092611-150203.
60. Martrus G, Nevot M, Andres C, Clotet B, Martinez MA. 2013. Changes in codon-pair bias of human immunodeficiency virus type 1 have pro-found effects on virus replication in cell culture. Retrovirology 10:78. http://dx.doi.org/10.1186/1742-4690-10-78.
61. Dixit E, Kagan JC. 2013. Intracellular pathogen detection by RIG-I-like receptors. Adv. Immunol. 117:99-125. http://dx.doi.org/10.1016/B978-0-12-410524-9.00004-9.
62. Rehwinkel J, Reis e Sousa C. 2010. RIGorous detection: exposing virus through RNA sensing. Science 327:284-286. http://dx.doi.org/10.1126/science.1185068.
63. Schlee M, Hartmann E, Coch C, Wimmenauer V, Janke M, Barchet W, Hartmann G. 2009. Approaching the RNA ligand for RIG-I? Immunol. Rev. 227:66-74. http://dx.doi.org/10.1111/j.1600-065X.2008.00724.x.
64. KoffWC, Johnson PR, Watkins DI, Burton DR, Lifson JD, Hasenkrug KJ, McDermott AB, Schultz A, Zamb TJ, Boyle R, Desrosiers RC. 2006. HIV vaccine design: insights from live attenuated SIV vaccines. Nat. Immunol. 7:19-23. http://dx.doi.org/10.1038/ni1296.
65. Whitney JB, Wainberg MA. 2007. Recovery of fitness of a live attenuated simian immunodeficiency virus through compensation in both the coding and non-coding regions of the viral genome. Retrovirology 4:44. http://dx.doi.org/10.1186/1742-4690-4-44.
66. Arya SK, Gallo RC. 1988. Human immunodeficiency virus type 2 long terminal repeat: analysis of regulatory elements. Proc. Natl. Acad. Sci. U. S. A. 85:9753-9757. http://dx.doi.org/10.1073/pnas.85.24.9753.
67. Browning MT, Mustafa F, Schmidt RD, Lew KA, Rizvi TA. 2003. Sequences within the gag gene of feline immunodeficiency virus (FIV) are important for efficient RNA encapsidation. Virus Res. 93:199-209. http://dx.doi.org/10.1016/S0168-1702(03)00098-4.
68. Mangeot PE, Negre D, Dubois B, Winter AJ, Leissner P, Mehtali M, Kaiserlian D, Cosset FL, Darlix JL. 2000. Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells. J. Virol. 74:8307-8315. http://dx.doi.org/10.1128/JVI.74.18.8307-8315.2000.
69. Le SY, Malim MH, Cullen BR, Maizel JV. 1990. A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses. Nucleic Acids Res. 18:1613-1623. http://dx.doi.org/10.1093/nar/18.6.1613.
70. Olsen HS, Beidas S, Dillon P, Rosen CA, Cochrane AW. 1991. Mutational analysis of the HIV-1 Rev. protein and its target sequence, the Rev responsive element. J. Acquir. Immune Defic. Syndr. 4:558-567.
71. Reinhart TA, Rogan MJ, Haase AT. 1996. RNA splice site utilization by simian immunodeficiency viruses derived from sooty mangabey monkeys. Virology 224:338-344. http://dx.doi.org/10.1006/viro.1996.0539.
72. Unger RE, Stout MW, Luciw PA. 1991. Simian immunodeficiency virus (SIVmac) exhibits complex splicing for tat, rev, and env mRNA. Virology 182:177-185. http://dx.doi.org/10.1016/0042-6822(91)90661-T.
73. Victoria JG, Robinson WE, Jr. 2005. Disruption of the putative splice acceptor site for SIV(mac239)Vif reveals tight control of SIV splicing and impaired replication in Vif non-permissive cells. Virology 338:281-291. http://dx.doi.org/10.1016/j.virol.2005.05.007.